Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
George G Zhanel, Tamiko Hisanaga, Aleksandra Wierzbowski & Daryl J Hoban. (2006) Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia. Therapeutics and Clinical Risk Management 2:1, pages 59-75.
Read now
Read now
. (2004) Comments on Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin and Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin or 10 days. Current Medical Research and Opinion 20:12, pages 1895-1897.
Read now
Read now
Articles from other publishers (7)
Jesús López-Alcalde, Ricardo Rodriguez-Barrientos, Jesús Redondo-Sánchez, Javier Muñoz-Gutiérrez, José María Molero García, Carmen Rodríguez-Fernández, Julio Heras-Mosteiro, Jaime Marin-Cañada, Jose Casanova-Colominas, Amaya Azcoaga-Lorenzo, Virginia Hernandez Santiago & Manuel Gómez-García. (2018) Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients. Cochrane Database of Systematic Reviews 2018:9.
Crossref
Crossref
Talitha I. Verhoef & Stephen Morris. (2015) Cost-effectiveness and Pricing of Antibacterial Drugs. Chemical Biology & Drug Design 85:1, pages 4-13.
Crossref
Crossref
Steven D Brown. (2008) Benefit-Risk Assessment of Telithromycin in the Treatment of Community-Acquired Pneumonia. Drug Safety 31:7, pages 561-575.
Crossref
Crossref
E. Denes. (2006) Quel antibiotique pour une pneumonie aiguë communautaire de l'adulte ?. Médecine et Maladies Infectieuses 36:11-12, pages 718-733.
Crossref
Crossref
Bernhard Schwarz & Sylvia Nanz. (2013) Eine Kostenanalyse von Telithromycin im Vergleich zu Clarithromycin und Amoxicillin/Clavulansäure in der Behandlung von Patienten mit ambulant erworbener Pneumonie oder akuter Exazerbation einer chronischen Bronchitis in ÖsterreichCost analysis of telithromycin versus clarithromycin and amoxicillin/clavulanic acid in the treatment of patients with community-acquired pneumonia or acute exacerbations of chronic bronchitis. PharmacoEconomics German Research Articles 4:1, pages 31-45.
Crossref
Crossref
Nishaminy Kasbekar & Pinak S. Acharya. (2005) Telithromycin: The first ketolide for the treatment of respiratory infections. American Journal of Health-System Pharmacy 62:9, pages 905-916.
Crossref
Crossref
George G. Zhanel, Christel Johanson, Tamiko Hisanaga, Chris Mendoza, Nancy Laing, Ayman Noreddin, Aleksandra Wierzbowski & Daryl J. Hoban. (2004) Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations. Journal of Antimicrobial Chemotherapy 54:6, pages 1072-1077.
Crossref
Crossref